- 2021
- Press releases - 31.03.2021
Huntington’s Disease: Exploring the Avenue of a Potential Neuroprotective Treatment
Huntington’s disease is a hereditary disorder that causes degeneration of the neurons involved in cognitive, motor and psychiatric functions. While existing treatments address the symptoms and relieve certain aspects of the disease, they cannot alter its course.
- Press releases - 31.03.2021
Discovery of a new variant of SARS-CoV-2 at Henri-Mondor AP-HP hospital
The “Henri-Mondor” variant, never described to date, was identified within a cluster made up of three hospital professionals and the spouse of one of them. It is now actively circulating in France.
- Press releases - 29.03.2021
COVID-19: A New Serological Test to Improve Monitoring of the Pandemic
A new test to detect antibodies to SARS-CoV-2 that is reliable, inexpensive and needs no special equipment? This is the proposal of an international scientific team, of which one of the members is an Inserm researcher at the Institute of Pharmacology and Structural Biology (CNRS/Université Toulouse III – Paul Sabatier). Developed in collaboration with the University of Oxford, this serological test is based on a single reagent that causes red blood cells to agglutinate in the presence of antibodies specific to SARS-CoV-2. Potential initial applications for this test include clinical and epidemiological research.
- Press releases - 24.03.2021
Air Pollution: Black Carbon Linked to Increased Cancer Risk
Air pollution is responsible for thousands of deaths each year in France. Knowing more about the health effects of its various components is therefore a priority. Scientists chose to focus on black carbon – a constituent of the fine particles produced by incomplete combustion, particularly related to automobile traffic. While it has already been associated with numerous health problems, this research suggests for the first time that long-term exposure to black carbon is also linked to an increased risk of cancer, particularly of the lungs.
- Press releases - 23.03.2021
Mental Health Deterioration in Lockdown: Results of a Mavie Cohort Study
Calyxis in Niort and the Inserm-Université de Bordeaux Population Health Research Center have published the findings of their study on the mental health impacts of lockdown in the journal Globalization and Health. Anxiety, depression, and self-rated mental health saw marked deteriorations in the MAVIE cohort, particularly in women, young people, elderly people, and those with less than 30 m2 of living space
- Press releases - 17.03.2021
COVIREIVAC Platform: COVID-19 Vaccine Research Continues with the Launch of New Projects
Launched in October last year, the purpose of the COVIREIVAC platform coordinated by Inserm and F-CRIN in conjunction with 32 university hospitals and a network of 11 immunology laboratories is to conduct and promote first-class clinical vaccination research in France.
- Press releases - 15.03.2021
Certains cocktails de pesticides favoriseraient le risque de cancer du sein chez les femmes ménopausées
Certains pesticides utilisés en Europe sont suspectés d’avoir des effets néfastes sur la santé humaine. Ils provoqueraient des perturbations hormonales et auraient également des propriétés carcinogènes, déjà observées en milieu professionnel. Le lien entre l’exposition à ces pesticides via l’alimentation et le cancer du sein dans la population générale est encore peu étudié.
- Press releases - 09.03.2021
Charcot-Marie Tooth disease: A 100% French RNA-based therapeutic innovation
Charcot-Marie Tooth disease is the most common hereditary neurological disease in the world. It affects the peripheral nerves and causes progressive paralysis of the legs and hands. No treatment is currently available to fight this disease, which is due to the overexpression of a specific protein.
- Press releases - 04.03.2021
COVID-19: Timing Issues Prevent SARS-CoV-2 Host Cells From Stopping Replication
Les cellules cibles du SARS-CoV-2 dans les voies respiratoires produisent des molécules antivirales suite à l’infection, mais trop tardivement pour empêcher la réplication du virus.
- Press releases - 25.02.2021
A Toxin Causing DNA Damage Found in Patients with Urinary Tract Infections
Urinary tract infections affect over 50% of women, in some cases recurrently. E. coli bacteria are very often implicated in their development.